MEDI8968, a fully human immunoglobulin G2 monoclonal antibody that binds selectively to IL-1R1 to inhibit its activation by IL-1α and IL-1β, has been investigated in subjects with rheumatoid arthritis [16] and osteoarthritis [17]. This evidence concerns the gene IL1R1 and rheumatoid arthritis.